Addus HomeCare Corporation Common Stock (ADUS)

FairStock Score: 74/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Addus is a home-care provider serving elderly, chronically ill, and disabled people through personal care, hospice, and home health. I like necessary services, but I want to see whether the numbers support the story. They mostly do. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $377.4 million, net income $27.6 million, and diluted EPS $1.49, compared with revenue of $349.4 million, net income of $22.1 million, and diluted EPS of $1.20 in fiscal Q2 2025. For FY2025, revenue was $1.4 billion, net income $95.9 million, and diluted EPS $5.22, versus FY2024 revenue of $1.2 billion, net income of $73.6 million, and diluted EPS of $4.23. That is a solid growth trajectory. The quality is mixed. FairStock calculations show ROE of 9.71% and ROCE of 6.27%, not exceptional, so I see no clear wide moat in the returns. The balance sheet is strong: D/E 0.09 and Altman Z-Score 5.11. Free cash flow was $154.8 million on a trailing basis, a 7.2% FCF yield against the $2.1 billion market cap at the $114.53 close on 2026-10-13. FairStock's Piotroski is 7/9. Valuation is the rub. FairStock's P/E is 20.02 and P/B is 1.82, while the Graham Number is $88.95. At $114.53, the price sits about 28.8% above that conservative value, so there is no Graham margin of safety. PEG is 0.79, and the FairStock Lynch category is FAST GROWER, based on 23.7% annual profit growth and 13.2% revenue growth over five years. In sum, a growing, low-debt, cash-generative business, but not a bargain; I would want better returns on capital or a lower price.

In plain English: Addus HomeCare helps older, chronically ill and disabled people live at home through personal care, hospice and home health services. The business is growing, profitable and carries little debt, though it does not earn especially high profits on the money it invests. At the recent price, the stock looks full compared with the value of its assets and earnings, but the growth record makes it look less expensive than that alone suggests.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer